The Italian company discusses the production of bulk active ingredients from the covid-19 vaccine.
‘Producing anti-covid vaccine in Italy from autumn’ was the topic of today’s meeting between industry minister Giancarlo Giorgetti and representatives of the Italian pharmaceutical industry.
Many companies in Italy will be ready to manufacture bulk medicinal ingredients – the active ingredients and other components of vaccines – “because they already have, or will soon have, the necessary bioreactors and fermentation equipment,” according to a statement from the industry ministry. .
Giorgetti also confirmed the government’s desire to set up a drug and vaccine research center in Italy, financed by public and private funds, Reuters reported.
Bulk vaccine production could potentially take off in four to six months, after regulatory authorization, the ministry statement said.
The head of the Italian drug agency AIFA and Italy’s new Covid-19 emergency commissioner Francesco Paolo Figliuolo also attended the meeting, the Italian news agency ANSA reported.
to request modification Contact us at Here or [email protected]